Cvirn G - Search Results

1

Hörl G, Ledinski G, Kager G, Hallström S, Tafeit E, Koestenberger M, Jürgens G, Cvirn G. Hörl G, et al. Among authors: cvirn g. Chem Phys Lipids. 2014 Oct;183:18-21. doi: 10.1016/j.chemphyslip.2014.05.002. Epub 2014 May 13. Chem Phys Lipids. 2014. PMID: 24835738

2

Effects of the glycoprotein IIb/IIIa receptor antagonist c7E3 Fab and anticoagulants on platelet aggregation and thrombin potential under high coagulant challenge in vitro.

Koestenberger M, Gallistl S, Cvirn G, Roschitz B, Muntean W. Koestenberger M, et al. Among authors: cvirn g. Blood Coagul Fibrinolysis. 2000 Jul;11(5):425-32. doi: 10.1097/00001721-200007000-00005. Blood Coagul Fibrinolysis. 2000. PMID: 10937803

3

Alpha 2-macroglobulin enhances prothrombin activation and thrombin potential by inhibiting the anticoagulant protein C/protein S system in cord and adult plasma.

Cvirn G, Gallistl S, Koestenberger M, Kutschera J, Leschnik B, Muntean W. Cvirn G, et al. Thromb Res. 2002 Mar 1;105(5):433-9. doi: 10.1016/s0049-3848(02)00042-7. Thromb Res. 2002. PMID: 12062545

4

Combined effects of eptifibatide and anticoagulants: differences between LMWH and UH or rH in thrombin generation inhibition but not in platelet aggregation inhibition.

Koestenberger M, Gallistl S, Cvirn G, Roschitz B, Petritsch M, Leschnik B, Muntean W. Koestenberger M, et al. Among authors: cvirn g. Thromb Haemost. 2002 Dec;88(6):1012-9. Thromb Haemost. 2002. PMID: 12529753

5

Elevated thrombin-forming capacity of tissue factor-activated cord compared with adult plasma.

Cvirn G, Gallistl S, Rehak T, Jürgens G, Muntean W. Cvirn G, et al. J Thromb Haemost. 2003 Aug;1(8):1785-90. doi: 10.1046/j.1538-7836.2003.00320.x. J Thromb Haemost. 2003. PMID: 12911594 Free article.

6

Modulation of LDL oxidation by 7,8-dihydroneopterin.

Greilberger J, Oettl K, Cvirn G, Reibnegger G, Jürgens G. Greilberger J, et al. Among authors: cvirn g. Free Radic Res. 2004 Jan;38(1):9-17. doi: 10.1080/10715760310001623322. Free Radic Res. 2004. PMID: 15061649

7

Combined effects of melagatran and eptifibatide on platelet aggregation inhibition but not thrombin generation inhibition.

Koestenberger M, Gallistl S, Cvirn G, Roschitz B, Rehak T, Leschnik B, Muntean W. Koestenberger M, et al. Among authors: cvirn g. Blood Coagul Fibrinolysis. 2004 Mar;15(2):131-7. doi: 10.1097/00001721-200403000-00004. Blood Coagul Fibrinolysis. 2004. PMID: 15091000

8

The anticoagulant action of recombinant human activated protein C (rhAPC, Drotrecogin alpha activated): comparison between cord and adult plasma.

Cvirn G, Gallistl S, Koestenberger M, Baier K, Fritsch P, Greilberger J, Jürgens G, Muntean W. Cvirn G, et al. Thromb Haemost. 2004 May;91(5):912-8. doi: 10.1160/TH03-12-0739. Thromb Haemost. 2004. PMID: 15116251

9

Anticoagulant action of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in umbilical cord and adult plasma: an in vitro examination.

Koestenberger M, Gallistl S, Cvirn G, Baier K, Leschnik B, Muntean W. Koestenberger M, et al. Among authors: cvirn g. Thromb Res. 2005;115(1-2):135-42. doi: 10.1016/j.thromres.2004.07.003. Thromb Res. 2005. PMID: 15567465

10

Drotrecogin alfa activated (recombinant human activated protein C) in combination with heparin or melagatran: effects on prothrombin time and activated partial thromboplastin time.

Koestenberger M, Cvirn G, Gallistl S, Muntean W. Koestenberger M, et al. Among authors: cvirn g. Blood Coagul Fibrinolysis. 2004 Oct;15(8):693-7. doi: 10.1097/00001721-200412000-00010. Blood Coagul Fibrinolysis. 2004. PMID: 15613925

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters